1. Home
  2. AKBA vs OFLX Comparison

AKBA vs OFLX Comparison

Compare AKBA & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.88

Market Cap

343.4M

Sector

Health Care

ML Signal

HOLD

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

HOLD

Current Price

$28.32

Market Cap

301.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
OFLX
Founded
2007
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
343.4M
301.1M
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
AKBA
OFLX
Price
$0.88
$28.32
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.67
N/A
AVG Volume (30 Days)
3.9M
38.5K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
4.05%
EPS Growth
93.94
N/A
EPS
N/A
0.47
Revenue
N/A
$98,296,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$137.19
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$25.58
52 Week High
$3.32
$37.92

Technical Indicators

Market Signals
Indicator
AKBA
OFLX
Relative Strength Index (RSI) 29.90 37.11
Support Level $0.85 $26.51
Resistance Level $1.54 $31.72
Average True Range (ATR) 0.07 1.03
MACD -0.05 -0.15
Stochastic Oscillator 7.30 17.60

Price Performance

Historical Comparison
AKBA
OFLX

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

Share on Social Networks: